pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4473 |
Genomic Coordinates | chr9: 20411148 - 20411238 |
Description | Homo sapiens miR-4473 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4473 | ||||||||||||||||||||||||||||||
Sequence | 57| CUAGUGCUCUCCGUUACAAGUA |78 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TPD52 | ||||||||||||||||||||
Synonyms | D52, N8L, PC-1, PrLZ, hD52 | ||||||||||||||||||||
Description | tumor protein D52 | ||||||||||||||||||||
Transcript | NM_001025252 | ||||||||||||||||||||
Other Transcripts | NM_001025253 , NM_005079 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TPD52 | |||||||||||||||||||||
3'UTR of TPD52 (miRNA target sites are highlighted) |
>TPD52|NM_001025252|3'UTR 1 GATTCCTACCTTTGTTCTGCTACCCACTGCCAGATGCTGCAAGCGAGGTCCAAGCACATCTTGTCAACATGCATTGCCAT 81 GAATTTCTACCAGATGTGCTTTTATTTAGCTTTACATATTCCTTTGACCAAATAGTTTGTGGGTTAAACAAAATGAAAAT 161 ATCTTCACCTCTATTCTTGGGAAACACCCTTTAGTGTACATTTATGTTCCTTTATTTAGGAAACACCATTATAAAAACAC 241 TTATAGTAAATGGGGACATTCACTATAATGATCTAAGAAGCTACAGATTGTCATAGTTGTTTTCCTGCTTTACAAAATTG 321 CTCCAGATCTGGAATGCCAGTTTGACCTTTGTCTTCTATAATATTTCCTTTTTTTCCCCTCTTTGAATCTCTGTATATTT 401 GATTCTTAACTAAAATTGTTCTCTTAAATATTCTGAATCCTGGTAATTAAAAGTTTGGGTGTATTTTCTTTACCTCCAAG 481 GAAAGAACTACTAGCTACAAAAAATATTTTGGAATAAGCATTGTTTTGGTATAAGGTACATATTTTGGTTGAAGACACCA 561 GACTGAAGTAAACAGCTGTGCATCCAATTTATTATAGTTTTGTAAGTAACAATATGTAATCAAACTTCTAGGTGACTTGA 641 GAGTGGAACCTCCTATATCATTATTTAGCACCGTTTGTGACAGTAACCATTTCAGTGTATTGTTTATTATACCACTTATA 721 TCAACTTATTTTTCACCAGGTTAAAATTTTAATTTCTACAAAATAACATTCTGAATCAAGCACACTGTATGTTCAGTAGG 801 TTGAACTATGAACACTGTCATCAATGTTCAGTTCAAAAGCCTGAAAGTTTAGATCTAGAAGCTGGTAAAAATGACAATAT 881 CAATCACATTAGGGGAACCATTGTTGTCTTCACTTAATCCATTTAGCACTATTTAAAATAAGCACACCAAGTTATATGAC 961 TAATATAACTTGAAAATTTTTTATACTGAGGGGTTGGTGATAACTCTTGAGGATGTAATGCATTAATAAAAATCAACTCA 1041 TCATTTTCTACTTGTTTTCAATGTGTTGGAAACTGTAAAATGATACTGTAGAACCTGTCTCCTACTTTGAAAACTGAATG 1121 TCAGGGCTGAGTGAATCAAAGTGTCTAGACATATTTGCATAGAGGCCAAGGTATTCTATTCTAATAACTGCTTACTCAAC 1201 ACTACCACCTTTTCCTTATACTGTATATGATTATGGCCTACAATGTTGTATTTGTTATTTATTAAATTGTGATTGTTTTA 1281 TTATTGTTTATGCCAAATGTTAACTGCCAAGCTTGGAGTGACCTAAAGCATTTTTTAAAAGCATGGCTAGATTTACTTCA 1361 GTATAAATTATCTTATGAAAACCAAATTTTAAAAGCCACAGGTGTTGATTGTTATAAAATAACATGCTGCCATTCTTGAT 1441 TGCTAGAGTTTTTGTTAGTACTTTGGATGCAATTAAAACTATGTGCTATCACATGTGAAAAGCTTAATAAATTCCATCTA 1521 TCAGTAGTATAGGTCTCAATATTTATTATGAGACCAGTGGTCTGGAAACAGCTTGTTGTACCGAATCAACTGGAGTCTAT 1601 GCTTAAAAAAAAAAAATTTTTTTTTAACCATCCTTAAATTATTGCTTAATGGTATCATATTAACATATTCTAAATAAGGG 1681 CTTTAAGGCACAGGCTGTTGAAGCATTTTCTCAGAGGAGTGGATCTGTAGAAGTCTGTCTTTCTATAGAAATATTGTGCT 1761 TACTCAAGTGTTAAATTATTTTTTCTATGAACTAGTCTACTTCTTAAAATTCAAACATATTCTTTTGATCACATTGTTTC 1841 TTGAGCATCCTGCCCTGCTACTAACTTTTCAACAAGGCAAAATGGAGTAAAGTGGCAATTTCTTTAGATGAGTGAAATAC 1921 CCTCAAGTCTCTTTTCTGCCCAAAAAGGGAAAAGTGATAGAAATGGGGGTGGCAAGTGGGGTGAGTGGATGAAGGTGGGT 2001 ATTGGGGGTGGCTGTGAAAGAAAATAATGGAGAATCACTTTTCTAGACATCTACCTATACTTAATCTAAGAAACAAAGTA 2081 ATCTACTGTAAAGTACTCTGCCCCTTGAAAGAAGTATTAAAAAGAGTGAGGATGGATTTAGAAAAAAACATGAATTTAGA 2161 AATATTCAAAATGGTTTTTGTGGCAGATTCAATATTATGAATTCACAGATATTTAAAGAATGAGAAACATAGTAATTAGT 2241 AGAAATGCCAGAAACAGTTCCTGGTTCCTCTTGTGTTTGACACTAAGAAAATAGCAAGAGTGTGAAATCTCAGATACTTA 2321 TGAAATCTCACAGATGTAAGGACTCAAGTGTAGAAGAAAATATCCCCTTCTTACAAAAAGAAATGTCAATTTATGGAGTT 2401 TGTGGGAAATAGGGCAAGAATTCTTATGCTTATGAGAGCCAAGTAGTCAGTGGAAGAGAGTAGAGCTCAAAACTGGATTA 2481 TCACCTTAGCAACTTAGAATAGTTTGAAATAGAAAAAAAGTATTTAATTTGGATCTGGATCTGTTAAGATATGCACAGTC 2561 TATTTTTTGTATAGTATTGGAAAATAAAAATGCTATAATTTGGGTATGGGTTCTTTTGTATACATTACCTGCCCATTGAG 2641 GAAAGGGGCAAGTCCATTATGCAACTTCTCTCCAAACCCTTCATATTCTGGATATGATACTTAAAGAGCCATGAGCAGCT 2721 ACATTCTGCCTATCAGAAGGCATTTATTAAATGACTGCTTGCTGAAGATGTGTCCAAAGAGATCCTACATTAAGGTCATT 2801 TGTCAGAATGATGTTTGTGTTTGTTTAGAGTTGGCTGACCTCCAACTCCTGGGGTCAAGGAATCCTACTGCCTTAGCTTC 2881 CCAAATAGCTAGGACTATAGGCATGCACCCGGCCATGTGTTTTATTTATAGCTCTTAAAGCCCAGATGAAGAAATCACAT 2961 TTTTGCCCATAGTGAAGAAACATTTGGCCATTGATTAGTCCTTATTTTCAGTGACTGTCCTGTTTTCATTAGATTAGAGA 3041 GACCCTGTGTGGGCCACAGTTAATATAAACCATTATCACTTTTAAGTAAACCTGCACATCTTAGATTTCATAATTTCCTT 3121 ATTGTTCTGACTCAAAATGAACTAAGAGCTTTTCACTTTTTGTTTGTAAGTTCTCAGAGAGTCGGGTCTGCAAGTGCTTT 3201 TGCCTGCCAGGATTTTGTACTCAAATAAATGCTATTTGGCAACTAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
PAR-CLIP data was present in GSM545217. RNA binding protein: AGO2. Condition:miR-7 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 7163.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000379096.5 | 3UTR | CACUAUUUAAAAUAAGCACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM545217 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-7 transfection |
Location of target site | ENST00000379096.5 | 3UTR | CACUAUUUAAAAUAAGCACACCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000379096.5 | 3UTR | UAGCACUAUUUAAAAUAAGCACACCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
53 hsa-miR-4473 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT193963 | GLCE | glucuronic acid epimerase | 2 | 2 | ||||||||
MIRT232832 | NUPL1 | nucleoporin 58 | 2 | 2 | ||||||||
MIRT306237 | ZMAT3 | zinc finger matrin-type 3 | 2 | 4 | ||||||||
MIRT441353 | ZNF75A | zinc finger protein 75a | 2 | 2 | ||||||||
MIRT443665 | FLT1 | fms related tyrosine kinase 1 | 2 | 2 | ||||||||
MIRT448553 | RAP1A | RAP1A, member of RAS oncogene family | 2 | 2 | ||||||||
MIRT448625 | OSBPL8 | oxysterol binding protein like 8 | 2 | 2 | ||||||||
MIRT449138 | UQCRB | ubiquinol-cytochrome c reductase binding protein | 2 | 2 | ||||||||
MIRT462942 | ZNF800 | zinc finger protein 800 | 2 | 12 | ||||||||
MIRT463962 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT466315 | THRA | thyroid hormone receptor, alpha | 2 | 2 | ||||||||
MIRT493504 | IL6ST | interleukin 6 signal transducer | 2 | 2 | ||||||||
MIRT502727 | CLIP1 | CAP-Gly domain containing linker protein 1 | 2 | 8 | ||||||||
MIRT503464 | ZNF154 | zinc finger protein 154 | 2 | 6 | ||||||||
MIRT506738 | LMLN | leishmanolysin like peptidase | 2 | 4 | ||||||||
MIRT507282 | FEM1B | fem-1 homolog B | 2 | 2 | ||||||||
MIRT510711 | SPG20 | spartin | 2 | 6 | ||||||||
MIRT524495 | CEP170 | centrosomal protein 170 | 2 | 4 | ||||||||
MIRT529425 | MALT1 | MALT1 paracaspase | 2 | 2 | ||||||||
MIRT533482 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT533715 | TMEM30A | transmembrane protein 30A | 2 | 2 | ||||||||
MIRT534115 | SOCS3 | suppressor of cytokine signaling 3 | 2 | 2 | ||||||||
MIRT534473 | SAR1B | secretion associated Ras related GTPase 1B | 2 | 2 | ||||||||
MIRT536519 | KCTD10 | potassium channel tetramerization domain containing 10 | 2 | 2 | ||||||||
MIRT537263 | GALNT3 | polypeptide N-acetylgalactosaminyltransferase 3 | 2 | 2 | ||||||||
MIRT537597 | ESRP2 | epithelial splicing regulatory protein 2 | 2 | 2 | ||||||||
MIRT537918 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT538074 | DIAPH2 | diaphanous related formin 2 | 2 | 2 | ||||||||
MIRT538707 | CAPRIN2 | caprin family member 2 | 2 | 4 | ||||||||
MIRT546187 | TPD52 | tumor protein D52 | 2 | 4 | ||||||||
MIRT546942 | SFTPA1 | surfactant protein A1 | 2 | 2 | ||||||||
MIRT549590 | TMEM101 | transmembrane protein 101 | 2 | 2 | ||||||||
MIRT551686 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT551948 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT553176 | UBE2D2 | ubiquitin conjugating enzyme E2 D2 | 2 | 2 | ||||||||
MIRT555074 | PURG | purine rich element binding protein G | 2 | 2 | ||||||||
MIRT556214 | MB21D2 | Mab-21 domain containing 2 | 2 | 2 | ||||||||
MIRT556476 | LIPA | lipase A, lysosomal acid type | 2 | 2 | ||||||||
MIRT556683 | KLHL28 | kelch like family member 28 | 2 | 2 | ||||||||
MIRT556863 | JMY | junction mediating and regulatory protein, p53 cofactor | 2 | 2 | ||||||||
MIRT558402 | DEPDC1 | DEP domain containing 1 | 2 | 2 | ||||||||
MIRT558716 | CLCN3 | chloride voltage-gated channel 3 | 2 | 2 | ||||||||
MIRT559512 | ARHGEF26 | Rho guanine nucleotide exchange factor 26 | 2 | 2 | ||||||||
MIRT566872 | LRP12 | LDL receptor related protein 12 | 2 | 2 | ||||||||
MIRT567038 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 2 | 2 | ||||||||
MIRT574515 | PRC1 | protein regulator of cytokinesis 1 | 2 | 2 | ||||||||
MIRT642220 | RABAC1 | Rab acceptor 1 | 2 | 2 | ||||||||
MIRT651915 | UEVLD | UEV and lactate/malate dehyrogenase domains | 2 | 2 | ||||||||
MIRT654128 | RPL14 | ribosomal protein L14 | 2 | 2 | ||||||||
MIRT654344 | RBM27 | RNA binding motif protein 27 | 2 | 2 | ||||||||
MIRT669250 | C4orf36 | chromosome 4 open reading frame 36 | 2 | 2 | ||||||||
MIRT683176 | UBL3 | ubiquitin like 3 | 2 | 2 | ||||||||
MIRT718768 | ABHD15 | abhydrolase domain containing 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|